Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| PROTAMINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 10MG | Updated Report | 2019-08-17 | 90060 |
| TERBINAFINE | SANIS HEALTH INC | Actual shortage | 250MG | Updated Report | 2019-08-17 | 90836 |
| FOMEPIZOLE FOR INJECTION | STERIMAX INC | Actual shortage | 1G | Updated Report | 2019-08-17 | 91678 |
| COZAAR | MERCK CANADA INC | Resolved | 100MG | Updated Report | 2019-08-17 | 88873 |
| APO-EMTRICITABINE-TENOFOVIR | APOTEX INC | Resolved | 300MG 200MG | Updated Report | 2019-08-17 | 89158 |
| BREVIBLOC PREMIXED INJECTION | BAXTER CORPORATION | Actual shortage | 10MG | Updated Report | 2019-08-17 | 91707 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-08-17 | 91720 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-08-17 | 91723 |
| COZAAR | MERCK CANADA INC | Actual shortage | 50MG | Updated Report | 2019-08-16 | 88869 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | BAXTER CORPORATION | Actual shortage | 900MG | Updated Report | 2019-08-16 | 91156 |
| TRICIRA LO | APOTEX INC | Actual shortage | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | Updated Report | 2019-08-16 | 80931 |
| APO-AMOXI CLAV | APOTEX INC | Actual shortage | 875MG 125MG | Updated Report | 2019-08-16 | 87057 |
| APO-OLMESARTAN | APOTEX INC | Actual shortage | 40MG | Updated Report | 2019-08-16 | 55287 |
| POTASSIUM CHLORIDE INJECTION | BAXTER CORPORATION | Actual shortage | 7.46MG | Updated Report | 2019-08-16 | 89426 |
| TWINRIX | GLAXOSMITHKLINE INC | Actual shortage | 720UNIT 20MCG | Updated Report | 2019-08-16 | 83033 |
| TRIZIVIR | VIIV HEALTHCARE ULC | Anticipated shortage | 300MG 300MG 150MG | Updated Report | 2019-08-16 | 90619 |
| JALYN | GLAXOSMITHKLINE INC | Resolved | 0.4MG 0.5MG | Updated Report | 2019-08-16 | 84337 |
| AURO-QUETIAPINE | AURO PHARMA INC | Actual shortage | 25MG | Updated Report | 2019-08-16 | 89540 |
| AURO-LACOSAMIDE | AURO PHARMA INC | Actual shortage | 100MG | Updated Report | 2019-08-16 | 90209 |
| AURO-BETAHISTINE | AURO PHARMA INC | Actual shortage | 16MG | New Report | 2019-08-16 | 91692 |
| AURO-RISEDRONATE | AURO PHARMA INC | Actual shortage | 35MG | Updated Report | 2019-08-16 | 87274 |
| AURO-REPAGLINIDE | AURO PHARMA INC | Actual shortage | 1MG | Updated Report | 2019-08-16 | 72027 |
| AURO-VENLAFAXINE XR | AURO PHARMA INC | Resolved | 75MG | Updated Report | 2019-08-16 | 90212 |
| MIDAZOLAM INJECTION | FRESENIUS KABI CANADA LTD | Actual shortage | 1MG | Updated Report | 2019-08-16 | 84727 |
| CEFAZOLIN FOR INJECTION | STERIMAX INC | Actual shortage | 10G | Updated Report | 2019-08-16 | 88566 |
| CEFAZOLIN FOR INJECTION | STERIMAX INC | Actual shortage | 1G | Updated Report | 2019-08-16 | 88563 |
| TEVA-NABILONE | TEVA CANADA LIMITED | Actual shortage | 1.0MG | Updated Report | 2019-08-16 | 91645 |
| TEVA-DOXYCYCLINE | TEVA CANADA LIMITED | Resolved | 100MG | Updated Report | 2019-08-16 | 87705 |
| PHARMA-AMLODIPINE | PHARMASCIENCE INC | Actual shortage | 10MG | Updated Report | 2019-08-16 | 88031 |
| PMS-SERTRALINE | PHARMASCIENCE INC | Actual shortage | 100MG | Updated Report | 2019-08-16 | 90485 |
| ACT LEVOFLOXACIN | TEVA CANADA LIMITED | Resolved | 750MG | Updated Report | 2019-08-16 | 68605 |
| CALMYLIN PSE WITH CODEINE | TEVA CANADA LIMITED | Resolved | 30MG 3.3MG 100MG | Updated Report | 2019-08-16 | 87659 |
| DIPYRIDAMOLE INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 5MG | Updated Report | 2019-08-16 | 88601 |
| AVAPRO | SANOFI-AVENTIS CANADA INC | Actual shortage | 300MG | Updated Report | 2019-08-16 | 89476 |
| AVALIDE | SANOFI-AVENTIS CANADA INC | Actual shortage | 12.5MG 300MG | Updated Report | 2019-08-16 | 89482 |
| IRBESARTAN | PRO DOC LIMITEE | Actual shortage | 300MG | Updated Report | 2019-08-16 | 91651 |
| MENACTRA | SANOFI PASTEUR LIMITED | Actual shortage | 4.0MCG 4.0MCG 4.0MCG 4.0MCG | Updated Report | 2019-08-15 | 91659 |
| DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML | PFIZER CANADA ULC | Anticipated shortage | 150MG | Updated Report | 2019-08-15 | 88645 |
| PRO-SOTALOL | PRO DOC LIMITEE | Anticipated shortage | 80MG | Updated Report | 2019-08-15 | 91654 |
| TEVA-ROSUVASTATIN | TEVA CANADA LIMITED | Actual shortage | 20MG | Updated Report | 2019-08-15 | 86917 |
| TEVA-ROSUVASTATIN | TEVA CANADA LIMITED | Actual shortage | 20MG | Updated Report | 2019-08-15 | 86914 |
| MAR-EZETIMIBE | MARCAN PHARMACEUTICALS INC | Resolved | 10MG | Updated Report | 2019-08-15 | 55366 |
| MAVIK | BGP PHARMA ULC | Anticipated shortage | 2MG | New Report | 2019-08-15 | 91626 |
| MAVIK | BGP PHARMA ULC | Anticipated shortage | 0.5MG | New Report | 2019-08-15 | 91623 |
| ISOPTIN SR | BGP PHARMA ULC | Anticipated shortage | 240MG | New Report | 2019-08-15 | 91620 |
| ANDROGEL | BGP PHARMA ULC | Resolved | 1% | Updated Report | 2019-08-15 | 82876 |
| ULTRA-TECHNEKOW V4 | CURIUM CANADA INC | Actual shortage | 19 CI / GEN | New Report | 2019-08-15 | 91615 |
| ULTRA-TECHNEKOW V4 | CURIUM CANADA INC | Actual shortage | 19 CI / GEN | New Report | 2019-08-15 | 91609 |
| MYLAN-TADALAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 5MG | Updated Report | 2019-08-15 | 45590 |
| MYLAN-TADALAFIL | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG | Updated Report | 2019-08-15 | 11788 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| TEVA-LISINOPRIL (TYPE Z) | TEVA CANADA LIMITED | Discontinued | 10MG | New Report | 2019-08-15 | 91648 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 1.5G 5.08MG 18.3MG 538MG | New Report | 2019-08-12 | 91388 |
| DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM | BAXTER CORPORATION | To be discontinued | 448MG 2.5G 5.08MG 18.3MG 538MG | New Report | 2019-08-12 | 91392 |
| DIANEAL PD 101 CAPD SOLUTION W 1.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 1.5G 15.2MG 23.9MG 567MG | New Report | 2019-08-12 | 91395 |
| DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE | BAXTER CORPORATION | To be discontinued | 392MG 2.5G 15.2MG 23.9MG 567MG | New Report | 2019-08-12 | 91399 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91385 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91382 |
| NUTRINEAL PD4 | BAXTER CORPORATION | To be discontinued | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | New Report | 2019-08-12 | 91378 |
| TRAMADOL / ACETAMINOPHEN | SIVEM PHARMACEUTICALS ULC | To be discontinued | 37.5MG 325MG | Updated Report | 2019-08-12 | 86439 |
| TETRACYCLINE | AA PHARMA INC | To be discontinued | 250MG | New Report | 2019-08-10 | 65441 |
